Published Online: Saturday, April 1, 2006

Reliant Pharmaceuticals Inc has warned pharmacists about recent confusion between its Omacor (omega-3-acid ethyl esters) capsules and Xanodyne Pharmaceuticals Inc's Amicar (aminocaproic acid) tablets. Omacor's manufacturer has informed pharmacists that telephone orders for its drug continue to be "misunderstood and dispensed" as Amicar.

FDA-approved Omacor is indicated as an adjunct to diet for the reduction of very high triglyceride levels. Amicar, however, is indicated for enhancing hemostasis when fibrinolysis contributes to bleeding. In certain patients, Amicar is prescribed for oral use to control acute or chronic bleeding syndromes.

Reliant issued a similar warning in November 2005. The company said that it was developing a "shelf talker" for pharmacists "to help prevent any more medication errors." For more information, visit

Latest Articles
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients.
Latest Issues